Health Catalyst Inc (NASDAQ:HCAT) price on Friday, December 27, fall -0.14% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $7.08.
A look at the stock’s price movement, the close in the last trading session was $7.09, moving within a range at $6.775 and $7.2. The beta value (5-Year monthly) was 1.325. Turning to its 52-week performance, $11.41 and $5.42 were the 52-week high and 52-week low respectively. Overall, HCAT moved -16.71% over the past month.
Health Catalyst Inc’s market cap currently stands at around $430.80 million, with investors looking forward to this quarter’s earnings report slated for in January.
Analysts have a consensus estimate of 80.68M for the company’s revenue for the quarter, with a low and high estimate of 78.51M and 82M respectively. The average forecast suggests up to a 7.46% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 307.67M, representing a 3.96% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that HCAT is a Hold. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
11 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 3 analyst(s) rate the stock as a Hold, 8 recommend HCAT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
HCAT’s current price about -9.36% and -11.40% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 37.39, while 7-day volatility ratio is 5.01% and 6.02% in the 30-day chart. Further, Health Catalyst Inc (HCAT) has a beta value of 1.34, and an average true range (ATR) of 0.45. Analysts have given the company’s stock an average 52-week price target of $11, forecast between a low of $7 and high of $11. Looking at the price targets, the low is 1.13% off current price level while to achieve the yearly target high, price needs to move -55.37%. Nonetheless, investors will most likely welcome a -55.37% jump to $11 which is the analysts’ median price.
If we refocus on Health Catalyst Inc (NASDAQ:HCAT), historical trading data shows that trading volumes averaged 0.52 over the past 10 days and 496.72K over the past 3 months. The company’s latest data on shares outstanding shows there are 60.85 million shares.
The 3.89% of Health Catalyst Inc’s shares are in the hands of company insiders while institutional holders own 87.54% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.55 million on 2024-11-29, giving us a short ratio of 5.03. The data shows that as of 2024-11-29 short interest in Health Catalyst Inc (HCAT) stood at 427.99999999999994 of shares outstanding, with shares short falling to 2.84 million registered in 2024-10-31. Current price change has pushed the stock -23.54% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the HCAT stock continues to rise going into the next quarter.
